UBS Group »

Neurosense Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Neurosense Therapeutics (NRSNW) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Neurosense Therapeutics

Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 20250100020003000400001000200030004000
Value ($)Share countHistorical NRSNW position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Neurosense Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurosense Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $41 94 0.44
2024-09-30 $28 200 0.14
2024-06-30 $124 605 0.21
2023-09-30 $422 3.8k 0.11
2022-12-31 $127 798 0.16
2022-09-30 $0 2.0k 0.00
2021-12-31 $4.0k 4.5k 0.89

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Neurosense Therapeutics

Clear Street
Citadel Advisors
Warberg Asset Management
UBS Group

View all funds holding Neurosense Therapeutics